|
|
Volumn 512, Issue , 2009, Pages 159-167
|
|
Development of a cell-based assay to quantify the inflammatory potential of test substances and screen compound libraries for anti-cancer drug candidates in a high-throughput format.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
DRUG;
TUMOR NECROSIS FACTOR ALPHA;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG SCREENING;
HELA CELL;
HUMAN;
INFLAMMATION;
ANTI-INFLAMMATORY AGENTS;
ANTINEOPLASTIC AGENTS;
DRUG SCREENING ASSAYS, ANTITUMOR;
HELA CELLS;
HUMANS;
INFLAMMATION;
PHARMACEUTICAL PREPARATIONS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 67650400513
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-60327-530-9_9 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
